Additionally, a rise in other cytokines, including IFN-α, IFN-γ, IL-10, CCL3, and CXCL10, was seen in both melanoma-treated groups receiving LIVP-RFP or LIVP-FlaB-RFP. This evidence concerns the gene CCL3 and melanoma.